News MSD opens $1bn plant for HPV vaccine in the US MSD has opened the doors of a $1bn facility at its site in Durham, North Carolina, that will be used to produce its HPV vaccine Gardasil.
News Servier will apply ‘digital twin’ tech to Parkinson’s drug French pharma Servier has enlisted the aid of ‘digital twin’ specialist Aitia for a third time, adding a Parkinson’s disease project to their prior collaborations on pancr
News Servier doubles up on ‘digital twin’ alliance with Aitia French pharma group Servier has formed a second partnership with Aitia focusing on the use of artificial intelligence and
Oncology BioNTech’s ASCO 2025 oncology advances: New data on bispecif... At ASCO 2025, BioNTech presented 7 abstracts on four selected pipeline candidates in mesothelioma, lung cancer, prostate cancer, and melanoma.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
